William B. Horne - Jan 24, 2022 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director
Signature
/s/ William B. Horne
Stock symbol
ALZN
Transactions as of
Jan 24, 2022
Transactions value $
$600
Form type
4
Date filed
1/25/2022, 04:00 PM
Previous filing
Dec 16, 2021
Next filing
Apr 28, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Options Exercise $600 +150K +150% $0.00* 250K Jan 24, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALZN Stock Options (Right to Buy) Options Exercise $0 -150K -6.25% $0.00 2.25M Jan 24, 2022 Common Stock 150K $0.00 Direct F2
holding ALZN Stock Options (Right to Buy) 250K Jan 24, 2022 Common Stock 250K $1.50 Direct F3
holding ALZN Stock Options (Right to Buy) 250K Jan 24, 2022 Common Stock 250K $1.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to Rule 16b-3 with shares of common stock received upon the exercise of stock options.
F2 The stock options exercised in this transaction were fully vested and exercisable as of the transaction date.
F3 The stock options vest ratably over thirty-six (36) months beginning on the date of grant.
F4 None of these performance-based stock options are vested or exercisable.